Four large drug companies reached a last-minute $260 million legal settlement over their role in the U.S. opioid addiction epidemic, averting the first federal trial that was scheduled to start Monday morning in Cleveland. The settlement covers drug distributors AmerisourceBergen Corp, Cardinal Health Inc and McKesson Corp and Israel-based drugmaker Teva Pharmaceutical Industries Ltd, and ends lawsuits by two Ohio counties. Hunter Shkolnik, an attorney for the counties, said Teva is paying $20 million in cash and will contribute $25 million worth of Suboxone, an opioid addiction treatme Drug distributor AmerisourceBergen, is among the four companies to settle before the start of a nine-week trial that was to start in Cleveland on Monday. The company’s office building in Conshohocken, Pennsylvania, is pictured above Cardinal Health’s corporate office in Dublin, Ohio, is pictured above. The company was among three drug makers to agree to a settlement in the opioid epidemic on Monday, avoiding a federal trial Drug distributor McKesson’s San Francisco office is pictured above. The drug distributor was among four companies that agreed to a settlement in the opioid crisis that has led to 400,000 overdose deaths since 1999. Israeli opioid-maker Teva’s office in Sens, south of Paris, is pictured. The… Read full this story
Three drug companies and an opioid manufacturer reach last-minute settlement with two Ohio counties to avoid federal trial that was set to begin today have 213 words, post on www.dailymail.co.uk at October 21, 2019. This is cached page on Europe Breaking News. If you want remove this page, please contact us.